Covered recipient · General Payments record
MADELEINE G SOWASH
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2023–2024
$1,213.71
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $837.72 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $169.77 | 4 |
| MERZ NORTH AMERICA, INC. | $137.58 | 1 |
| ABBVIE INC. | $87.31 | 4 |
| Amgen Inc. | $84.60 | 3 |
| LEO Pharma Inc. | $75.17 | 3 |
| GENZYME CORPORATION | $63.72 | 3 |
| Regeneron Healthcare Solutions, Inc. | $55.65 | 2 |
| Incyte Corporation | $55.15 | 2 |
| Lilly USA, LLC | $48.42 | 2 |
| UCB, Inc. | $22.45 | 1 |
| Janssen Biotech, Inc. | $22.32 | 1 |
| Verrica Pharmaceuticals Inc. | $15.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.68 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106143334 | CMS |
| ABBVIE INC. | $15.49 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106143336 | CMS |
| ABBVIE INC. | $23.43 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106143338 | CMS |
| ABBVIE INC. | $14.71 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106143340 | CMS |
| Amgen Inc. | $30.67 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117388756 | CMS |
| Amgen Inc. | $23.70 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117388758 | CMS |
| Amgen Inc. | $30.23 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117388760 | CMS |
| GENZYME CORPORATION | $21.12 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139941173 | CMS |
| GENZYME CORPORATION | $20.97 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139941213 | CMS |
| GENZYME CORPORATION | $21.63 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139941251 | CMS |
| Incyte Corporation | $25.80 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141173715 | CMS |
| Incyte Corporation | $29.35 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141196829 | CMS |
| Janssen Biotech, Inc. | $22.32 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078790786 | CMS |
| LEO Pharma Inc. | $29.33 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152652461 | CMS |
| LEO Pharma Inc. | $22.92 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152652463 | CMS |
| LEO Pharma Inc. | $22.92 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152652465 | CMS |
| Lilly USA, LLC | $27.12 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135162043 | CMS |
| Lilly USA, LLC | $21.30 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135161937 | CMS |
| MERZ NORTH AMERICA, INC. | $137.58 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146372662 | CMS |
| PFIZER INC. | $18.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132044102 | CMS |
| PFIZER INC. | $120.69 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132050912 | CMS |
| PFIZER INC. | $11.77 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132066405 | CMS |
| PFIZER INC. | $19.31 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132058358 | CMS |
| Regeneron Healthcare Solutions, Inc. | $30.46 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114188089 | CMS |
| Regeneron Healthcare Solutions, Inc. | $25.19 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114188095 | CMS |
| UCB, Inc. | $22.45 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143439441 | CMS |
| Verrica Pharmaceuticals Inc. | $15.58 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118387092 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.